Top 10 Emerging Players in the Vietnam Ankylosing Spondylitis Market | Insights 2026

Top 10 Emerging Players in the Vietnam Ankylosing Spondylitis Market

The Vietnam Ankylosing Spondylitis Market is shaped by prominent pharmaceutical companies offering innovative biologics and biosimilars. Key players contributing to advancements in treatment options for this chronic condition include AbbVie Inc., Novartis AG, Pfizer Inc., and Amgen Inc.,

Vietnam Ankylosing Spondylitis Market Overview

According to 6Wresearch, the market for ankylosing spondylitis is currently undergoing tremendous growth, due to the increasing prevalence of the condition and the growing need for effective treatment solutions. Ankylosing Spondylitis is a chronic inflammatory disease that affects the spine and other joints, hence the need for proper management.

Today, the market is driven by the growing trend of using biologics and biosimilars, which offer patients effective solutions, hence the ability to manage the condition effectively. In addition, various initiatives have been put in place by the government to ensure improved healthcare services and expanded universal health coverage, thus driving market growth.

Competitive Landscape

The competitive landscape of the Vietnam ankylosing spondylitis Industry encompasses several global manufacturers, especially in the biologics and biosimilars sectors. The market position of the dominant companies in the market is sustained with continued investment in R&D, which helps in the development of innovative drugs, thus catering to the growing need for effective ankylosing spondylitis drugs.

Below is a list of leading players operating in the Vietnam Ankylosing Spondylitis Market:

1. AbbVie Vietnam

AbbVie is a dominant leader, with its portfolio of TNF inhibitors being widely used in rheumatology departments across Vietnam.

2. Novartis Vietnam

Novartis provides essential IL-17A antagonists that form the backbone of advanced chronic management for ankylosing spondylitis.

3. Pfizer Vietnam

Pfizer is a major player in the biosimilars segment and focuses on providing cost-effective TNF-inhibiting solutions for patients.

4. Johnson & Johnson (Janssen) Vietnam

Janssen maintains a strong presence through its innovative monoclonal antibodies tailored for long-term autoimmune disease management.

5. Roche Vietnam

Roche is a key player in providing high-end diagnostic tools and specialized biological therapies for inflammatory conditions.

6. Amgen Vietnam

Amgen focuses on biosimilar versions of standard biologics designed to increase patient access to therapy.

7. Takeda Vietnam

Takeda provides critical inflammation-focused treatments used in both clinical and hospital settings for spinal health.

8. Sanofi Vietnam

Sanofi specializes in a broad range of anti-inflammatory medications and is active in distributing autoimmune treatments across hospital networks.

9. Vietnam Medical Equipment Corporation (VINAMED)

VINAMED is a leading manufacturer and distributor that partners with global firms to bring specialized diagnostic imaging and therapeutic tools.

10. Vimedimex Medi-Pharma

Vimedimex is a local leader that provides a wide range of imported rheumatology drugs and supports the supply chain for advanced biologics.

Top 10 Emerging Players in the Vietnam Ankylosing Spondylitis Market: FAQs